CHN1
MCID: NRP063
MIFTS: 58
|
Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive (CHN1)
Categories:
Genetic diseases, Muscle diseases, Neuronal diseases, Rare diseases, Respiratory diseases
|
|
Aliases & Classifications for Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive
MalaCards integrated aliases for Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive:
Characteristics:Orphanet epidemiological data:58
charcot-marie-tooth disease type 4
Inheritance: Autosomal recessive; Prevalence: 1-5/10000 (Europe); Age of onset: Childhood;
charcot-marie-tooth disease type 4e
Inheritance: Autosomal recessive; Age of onset: Infancy,Neonatal; OMIM®:57 (Updated 05-Mar-2021)
Inheritance:
autosomal recessive autosomal dominant (in 1 patient)
Miscellaneous:
onset at birth usually begins in feet and legs (peroneal distribution) upper limb involvement may occur later one patient with sporadic occurrence (autosomal dominant) and a de novo mutation has been reported HPO:31
neuropathy, congenital hypomyelinating, 1, autosomal recessive:
Inheritance autosomal dominant inheritance autosomal recessive inheritance Onset and clinical course congenital onset Classifications:
MalaCards categories:
Global: Genetic diseases Rare diseases Anatomical: Neuronal diseases Muscle diseases Respiratory diseases
ICD10:
32
33
Orphanet: 58
![]() External Ids:
|
OMIM® :
57
Congenital hypomyelinating neuropathy (CHN) is characterized clinically by onset of hypotonia at birth, areflexia, distal muscle weakness, and very slow nerve conduction velocities (often less than 10 m/s). 5,4:Warner et al. (1997, 1998) noted that pathologic findings on sural nerve biopsies show hypomyelination of most or all fibers. Based on these findings, CHN is considered to be a result of congenital impairment in myelin formation.
There has been some controversy and difficulty in differentiating congenital hypomyelination from Dejerine-Sottas syndrome (DSS; 145900) because there is considerable overlap in clinical presentation. Based on pathologic findings of sural nerve biopsies (the absence of active myelin breakdown and the paucity of the onion bulbs in CHN and the presence of demyelination/remyelination and an abundance of well-organized onion bulbs in DSS; see Balestrini et al., 1991), CHN is considered to result from a congenital impairment in myelin formation, whereas DSS is thought to be due to aberrant demyelination and subsequent remyelination of the peripheral nerve.
There is also variation in the prognosis of patients diagnosed with CHN. In patients with CHN, Harati and Butler (1985) showed correlation of morbidity and mortality with the presence/absence of onion bulbs: patients with few onion bulbs died in early infancy, usually because of difficulty in swallowing and respiration after birth. Patients with atypical onion bulbs survived but were affected with severe motor and sensory impairment. These differences in outcome may represent genetic heterogeneity such that mutations in essential early myelin gene(s) cause a severe phenotype, whereas mutations in other, possibly later acting gene(s), such as MPZ, lead to a less severe outcome.
(605253) (Updated 05-Mar-2021)
MalaCards based summary : Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive, also known as charcot-marie-tooth disease type 4, is related to charcot-marie-tooth disease, demyelinating, type 1b and charcot-marie-tooth disease, demyelinating, type 1a. An important gene associated with Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive is EGR2 (Early Growth Response 2), and among its related pathways/superpathways is Neural Crest Differentiation. The drug Ethanol has been mentioned in the context of this disorder. Affiliated tissues include Peripheral Nervous System, and related phenotypes are respiratory insufficiency and neonatal hypotonia Disease Ontology : 12 A Charcot-Marie-Tooth disease characterized by demyelinating or axonal abnormalities that has material basis in autosomal recessive inheritance. GARD : 20 Charcot-Marie-Tooth type 4 (CMT4) is a congenital neurologic hereditary disease, part of a group of peripheral neuropathies known as Charcot-Marie-Tooth disease (CMT). According to the mutated gene CMT4 is classified in CMT4A, CMT4B1, CMT4B2, CMT4B3, CMT4C, CMT4D, CMT4E, CMT4F, CMT4G, CMT4H and CMT4J. Each of these subtypes is very rare and may affect only a particular ethnic group. CMT4 causes weakness, usually mostly distal (situated away from the center of the body) but sometimes involving proximal (near the center of the body) muscles. The most common symptoms are walking difficulties with steppage gait or an abnormally high arched foot (pes cavus) pes cavus. Hammer toes and other skeletal deformities, such as an abnormal lateral curvature of the spine (scoliosis), are often observed. Some affected people have changes in sensations (such as the sense of touch or ability to perceive temperature changes). When CMT4 begins in infancy, it is characterized by low muscle tone. CMT4 patients may also develop other symptoms such as cataracts or deafness. Generally, cases of CMT4 present earlier and with more severe symptoms compared to CMT1 or CMT2. Subtypes may have different clinical features among them. Several genes have been identified as causing CMT4, including GDAP1 (CMT4A), MTMR13 (CMT4B1), MTMR2 (CMT4B2), SBF1 (CMT4B3), SH3TC2 (CMT4C), NDG1(CMT4D), EGR2 (CMT4E), PRX (CMT4F), FDG4 (CMT4H), and FIG4 (CMT4J). CMT4 inheritance is autosomal recessive. Treatment is symptomatic and includes physical therapy, corrective surgery (when needed) and pain medication. KEGG : 36 Congenital hypomyelinating neuropathy (CHN) is a rare congenital neuropathy, often accompanied by arthrogryposis, that is characterized by prenatal onset, areflexia, hypotonia, hypomyelination, and slowed nerve conduction velocities. Previous reports of genetic analyses of patients have described mutations in genes known to be important in myelination. UniProtKB/Swiss-Prot : 73 Neuropathy, congenital hypomyelinating, 1, autosomal recessive: A severe degenerating neuropathy that results from a congenital impairment in myelin formation. It is clinically characterized by early onset of hypotonia, areflexia, distal muscle weakness, and very slow nerve conduction velocities (as low as 3m/s). Some patients manifest nearly complete absence of spontaneous limb movements, respiratory distress at birth, and complete absence of myelin shown by electron microscopy of peripheral nerves. |
Human phenotypes related to Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive:31 (show all 12)
Symptoms via clinical synopsis from OMIM®:57 (Updated 05-Mar-2021)Clinical features from OMIM®:605253 (Updated 05-Mar-2021)MGI Mouse Phenotypes related to Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive:46
|
Drugs for Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
Interventional clinical trials:
|
Genetic tests related to Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive:
|
![]() Data from LifeMap, the Embryonic Development and Stem Cells Database
Cells/anatomical compartments in embryo or adult related to Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive:
|
Articles related to Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive:(show all 33)
|
ClinVar genetic disease variations for Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive:6 (show top 50) (show all 1980)
UniProtKB/Swiss-Prot genetic disease variations for Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive:73
|
Search
GEO
for disease gene expression data for Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive.
|
Cellular components related to Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive according to GeneCards Suite gene sharing:
Biological processes related to Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive according to GeneCards Suite gene sharing:
Molecular functions related to Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive according to GeneCards Suite gene sharing:
|
|